10-QPeriod: Q1 FY2021

MICROCHIP TECHNOLOGY INC Quarterly Report for Q1 Ended Jun 30, 2020

Filed August 4, 2020For Securities:MCHPMCHPP

Summary

Microchip Technology Inc. (MCHP) reported its financial results for the first quarter of fiscal year 2021, ending June 30, 2020. The company experienced a slight decrease in net sales year-over-year, reflecting a mixed demand environment influenced by the COVID-19 pandemic. While demand weakened in some sectors like automotive and industrial, it strengthened in areas supporting the stay-at-home economy, such as medical devices and datacenters. The company demonstrated solid operational execution by managing expenses effectively, leading to an increase in net cash provided by operating activities. Significant financing activities occurred, including the issuance of new notes and the settlement of convertible debt, aimed at optimizing the company's debt structure. Microchip continues to invest in its product portfolio and manufacturing capabilities while navigating the ongoing economic uncertainties.

Financial Statements
Beta
Revenue$1.31B
Cost of Revenue$511.40M
Gross Profit$798.30M
R&D Expenses$198.00M
SG&A Expenses$146.30M
Operating Expenses$580.00M
Operating Income$218.30M
Interest Expense$99.10M
Net Income$123.60M
EPS (Basic)$0.25
EPS (Diluted)$0.24
Shares Outstanding (Basic)495.40M
Shares Outstanding (Diluted)515.60M

Key Highlights

  • 1Net sales for the quarter were $1,309.7 million, a slight decrease of 1.0% compared to $1,322.6 million in the same quarter last year, impacted by mixed demand due to the COVID-19 pandemic.
  • 2Gross profit margin was 61.0%, slightly down from 61.6% in the prior year, influenced by unabsorbed capacity charges and product mix.
  • 3Operating income increased to $218.3 million from $171.6 million in the prior year, driven by a reduction in operating expenses.
  • 4Net income significantly improved to $123.6 million, or $0.48 per diluted share, compared to $50.7 million, or $0.20 per diluted share, in the prior year.
  • 5Net cash provided by operating activities increased to $501.8 million from $380.6 million in the prior year.
  • 6The company executed significant debt management activities, including issuing new senior notes and settling convertible debt, resulting in net cash used in financing activities of $507.7 million.
  • 7Cash and cash equivalents decreased by $22.8 million to $378.2 million at the end of the quarter.

Frequently Asked Questions